BARECETAMAB

Approval Year

Name

Type

Language

BARECETAMAB

Official Name

English

IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HOMO SAPIENS ERBB3 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3, HER3)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-451) (VH (HOMO SAPIENS IGHV3-23*01 (90.8%)-(IGHD)-IGHJ4*01 (100%)) CDR-IMGT (8.8.14)

Common Name

English

Barecetamab [WHO-DD]

Common Name

English

ISU104

Code

English

barecetamab [INN]

Common Name

English

ISU-104

Code

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER3) (HUMAN MONOCLONAL ISU104 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ISU104 .LAMBDA.-CHAIN, DIMER

Common Name

English

Code System Code Type Description

NCI_THESAURUS

C158746

Created by admin on Sat Dec 16 16:11:40 GMT 2023 , Edited by admin on Sat Dec 16 16:11:40 GMT 2023

PRIMARY

INN

11386

Created by admin on Sat Dec 16 16:11:40 GMT 2023 , Edited by admin on Sat Dec 16 16:11:40 GMT 2023

PRIMARY

FDA UNII

M9SE4M9U1V

Created by admin on Sat Dec 16 16:11:40 GMT 2023 , Edited by admin on Sat Dec 16 16:11:40 GMT 2023

PRIMARY

CAS

2275727-74-5

Created by admin on Sat Dec 16 16:11:40 GMT 2023 , Edited by admin on Sat Dec 16 16:11:40 GMT 2023

PRIMARY

ACTIVE MOIETY


					M9SE4M9U1V

BARECETAMAB